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Abstract
Topological, chemical and immunological barriers are thought to limit infection by enteropathogenic bacteria. However, in
many cases these barriers and their consequences for the infection process remain incompletely understood. Here, we
employed a mouse model for Salmonella colitis and a mixed inoculum approach to identify barriers limiting the gut luminal
pathogen population. Mice were infected via the oral route with wild type S. Typhimurium (S. Tm) and/or mixtures of
phenotypically identical but differentially tagged S. Tm strains (‘‘WITS’’, wild-type isogenic tagged strains), which can be
individually tracked by quantitative real-time PCR. WITS dilution experiments identified a substantial loss in tag/genetic
diversity within the gut luminal S. Tm population by days 2–4 post infection. The diversity-loss was not attributable to
overgrowth by S. Tm mutants, but required inflammation, Gr-1+ cells (mainly neutrophilic granulocytes) and most likely
NADPH-oxidase-mediated defense, but not iNOS. Mathematical modelling indicated that inflammation inflicts a bottleneck
transiently restricting the gut luminal S. Tm population to approximately 6000 cells and plating experiments verified a
transient, inflammation- and Gr-1+ cell-dependent dip in the gut luminal S. Tm population at day 2 post infection. We
conclude that granulocytes, an important clinical hallmark of S. Tm-induced inflammation, impose a drastic bottleneck upon
the pathogen population. This extends the current view of inflammation-fuelled gut-luminal Salmonella growth by
establishing the host response in the intestinal lumen as a double-edged sword, fostering and diminishing colonization in a
dynamic equilibrium. Our work identifies a potent immune defense against gut infection and reveals a potential Achilles’
heel of the infection process which might be targeted for therapy.
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Introduction
Acute infections constitute highly complex interactions between
pathogens and their hosts. The complexity arises from dynamic
changes in pathogen gene expression, pathogen growth, barriers
limiting the initial colonization and host defenses which limit
further pathogen growth and survival during the course of an
infection. Identifying the relevant interactions and how they affect
the progression of the disease is of great value for understanding
the infection process and may reveal new targets for prevention or
therapy.
Mixed inoculation provides a powerful approach to decipher
pathogen-host interactions [1]. In such experiments, genetic
markers carried by some members of the pathogen population
are used to follow how the pathogen population disseminates,
grows or is killed during the course of an infection [2–13]. This
can reveal ‘‘barriers’’, which limit the infection. Barriers can be of
varying nature, including chemical barriers (i.e. antimicrobial
peptides, stomach acid), physical obstacles (e.g. the mucus layer
separating gut luminal bacteria from the epithelial surface [14]) or
immune responses killing the pathogen. Such barriers can impose
‘‘bottlenecks’’ onto the pathogen population which can be
detected as loss of marker diversity. Thus, barriers are important
characteristics of an infection process as they indicate how hosts
can interfere with pathogen colonization and survival.
We employed a mixed inoculum approach to study Salmonella
enterica subspecies 1 serovar Typhimurium (termed S. Tm
hereafter) growth in the inflamed gut using the well-established
streptomycin mouse model for Salmonella colitis [15]. In this
model, the resident microbiota is transiently suppressed by a single
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dose of streptomycin [16]. This bypasses the initial phase of the
natural infection where the pathogen has to competitively grow in
the face of an intact, dense microbiota [17] and allows us to focus
on the next stage where the pathogen triggers disease and grows in
the inflamed gut [15], which is still incompletely understood.
S. Tm mainly elicits mucosal inflammation via virulence
factors encoded in genomic islands, i.e. the SPI-1 and SPI-2
type III secretion systems [18,19]. The inflammatory response
has been shown to foster efficient colonization of the host’s gut
lumen by the pathogen, as the milieu in the inflamed gut can
help the pathogen to outcompete and/or suppress the resident
microbiota [20]. Some of the molecular mechanisms have been
identified [15]. This includes the elicitation of antimicrobial
peptides which kill some of the microbiota (but not S. Tm;
[21]), the limitation of iron and zinc uptake by microbiota
species (but not S. Tm; [22,23]) and the provision of terminal
electron acceptors fuelling S. Tm growth by anaerobic
respiration [24,25]. These findings have established S. Tm as
a pathogen subverting gut luminal inflammation to efficiently
colonize this niche. However, it was previously unclear
whether the inflammatory response also inflicts an additional
barrier limiting pathogen colonization of the gut. This would
seem reasonable as inflammation is generally mounted to fight
infection, i.e. in infected host tissues [26,27]. Indeed, some
studies have observed transient, 10-fold reductions of gut
luminal pathogen loads at day 2 p.i. [20] and Reg3b, an
antimicrobial peptide released by the inflamed mucosa, was
found to kill fast-growing S. Tm cells [28].
In this study, we have employed a mixed inoculum approach to
identify barriers limiting gut luminal colonization by S. Tm. Using
S. Tm strains chromosomally tagged with bar coded sequences
(WITS, wild-type isogenic tagged strains; [5,6,29]) we identified a
pronounced bottleneck in the gut luminal pathogen population
and oligo-clonal expansion post crisis. The barrier was attributable
to pathogen-induced inflammation, in particular granulocytes, a
prominent phagocytic cell type infiltrating the infected mucosa
and the gut lumen. Our data extend the current paradigm by
establishing that not only the tissue-infiltrating bacteria, but also
the gut luminal pathogen population, can be temporarily restricted
by the host’s inflammatory response.
Results
WITS infections reveal neutral genetic diversity loss by
S. Tm in the cecum lumen and feces of streptomycin
pretreated mice
To identify barriers limiting gut luminal pathogen colonization,
we monitored the S. Tm community composition by using seven
wild-type isogenic tagged S. Tm strains (WITS), which are
phenotypically identical (S1 Figure). Each WITS harbors a 40
nucleotide ‘‘bar code’’ between two pseudogenes which allow
quantification of their relative proportion by rtqPCR [5,6,30]. In
case of perturbations, the equal proportions of the WITS-tagged
subpopulations will shift towards an uneven population structure
in which some WITS are dominant while others disappear (i.e. loss
of diversity; reduced ‘‘evenness’’). Dilution of the tagged strains by
untagged S. TmWT probes the degree of diversity loss (S1C
Figure).
First, we screened for optimal assay conditions by titrating the
fraction of tagged WITS strains in the inoculum. A ‘‘1:7’’
inoculum was prepared by mixing seven different WITS at an
equal ratio (1:1:1:1:1:1:1; S1 Figure). The ‘‘1:70’’, 1:700’’ and
‘‘1:7000’’ inocula were generated by diluting the original WITS
mixture with an untagged, isogenic wild type strain (1:10, 1:100
and 1:1000, respectively). Streptomycin pretreated C57BL/6 mice
were infected with the indicated inocula (56107 cfu total, by
gavage; without sodium bicarbonate-mediated neutralization of
stomach acid, 2 independent experiments using a total of 5 or 6
mice per group) and we monitored pathogen loads in the stool by
plating fecal pellets (day 1 p.i.), the cecal content, the mesenteric
lymph nodes (mLN), the livers and the spleens (day 4 p.i.). All
animals featured high pathogen loads in the feces at day 1 and in
the cecum lumen at day 4 p.i. (<109 cfu/g; Fig. 1A–D, black
bars). Furthermore, we observed efficient colonization of the mLN,
spleen and liver and all mice displayed profound cecum
inflammation by day 4 p.i. (Fig. 1E). This is well in line with
previous work [16,19] and verified that the tags do not interfere
with the infection process.
To detect diversity loss and identify optimal assay conditions, we
quantified each WITS in the inoculum, the feces (day 1 p.i.) and
the cecum content (day 4 p.i.). To analyze the WITS-diversity in a
quantitative fashion, we have used the ‘‘evenness index’’, an
indicator commonly used to describe differences in the distribution
of goods or money in a society ( = Gini-index [31]; see also S1
Figure). In our experiments, this index had a value close to 1 in the
inoculum (0.913, median). Slight deviations (i.e. values from 0.9
to 1) are most likely attributable to technical errors (e.g. pipetting
errors, PCR bias, cfu determination, DNA recovery, enrichment
culture, etc.), not loss of genetic diversity in the biological system
(S2 Figure).
At day 1 p.i., all WITS were detectable in the feces, no matter
which inoculum was applied, and evenness indices ranged from
0.914–0.950 (1:7 inoculum; median = 0.939) to 0.833–0.893
(1:7000 inoculum; median = 0.868; Fig. 1A–D). This high degree
of evenness indicated that the population did not encounter
detectable bottlenecks, ‘‘selective sweeps’’ [32] or other effects
limiting the genetic diversity during the transit through the
gastrointestinal tract or the initial colonization of the host’s large
intestinal lumen by day 1 p.i.
Author Summary
Salmonella Typhimurium can colonize the human intestine
and cause severe diarrhea. In recent years, it has become
clear that this pathogen profits from inflammatory
changes in the intestinal lumen, as the inflamed gut helps
Salmonella to out-compete the resident microbiota.
Granulocytes transmigrating into the gut lumen were
found to ‘‘foster’’ luminal Salmonella growth by providing
nutrients (used by Salmonella, not the microbiota) and by
releasing growth inhibitors affecting the microbiota, but
not the pathogen. In this study, we extend this ‘‘fostering’’
concept by showing that gut luminal Salmonella Typhi-
murium population is itself surprisingly vulnerable to the
host’s inflammatory response. Indeed, inflammation re-
duces the size of the gut luminal Salmonella population by
as much as 105-fold at day 2 post infection. Thus,
triggering of mucosal inflammation is in fact a double-
edged sword by providing S. Typhimurium with a relative
growth advantage against the microbiota in the gut lumen
and by killing 99.999% of the gut luminal pathogen
population at day 2. However, the pathogen population
can recover and grow up again during the subsequent
days. This changes the current view: Inflammation is not
simply ‘‘beneficial’’ for the pathogen in the gut lumen.
Instead, pathogen growth in the inflamed gut must be
considered as an equilibrium between inflammation-
inflicted killing and fostering growth of the surviving
bacteria.
Inflammation-Mediated Population Bottleneck during S. Tm Colitis
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Fig. 1. Systematic dilution experiments of the tagged S. TmWT strains allow assessing the level of WITS diversity loss. Infections were
performed by diluting the tagged S. TmWT WITS with the untagged isogenic strain to a final proportion of (A) 1:7, (B) 1:70, (C) 1:700, (D) 1:7000 of each
strain. The population composition was monitored in fecal samples at day 1 post infection (day 1 p.i.) and in cecal content at day 4 post infection (day
4 p.i.) of each mouse (individual mouse identifiers were plotted on the x-axis). The cfu/g fecal or cecal content for the whole population and each
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In stark contrast, we detected dramatically reduced evenness
indices of cecum luminal S. Tm populations at day 4 p.i., in
particular at the highest WITS-dilutions (1:7000; median = 0.033;
Table 1). In the 5 mice, 18 of the 35 WITS were lost from the
cecum lumen at day 4, and one animal did not retain any
detectable WITS (mouse #G752; Fig. 1D). The identity of the
dominant WITS and the WITS lost from the population differed
from animal to animal and from experiment to experiment
(Fig. 1A–D, see color code). These observations provided addi-
tional evidence that all WITS had equivalent fitness in our model
and suggested that the diversity is reduced by a stochastic process.
Formally, the reduced evenness observed at higher WITS-
dilutions could be explained either by bottlenecks in the pathogen
population or by selective sweeps (e.g. up-growth of fitter S. Tm
mutants [33]). The latter was ruled out in competitive infections
with re-isolated clones. These control experiments verified that (in
general), the dominant WITS-isolates retained the fitness of the
original strain (S3 Figure). Thus, selective sweeps [32] of beneficial
mutations cannot explain the loss of WITS-diversity in the
experiment shown in Fig. 1. Therefore, these data provided a first
hint that a bottleneck might limit the diversity of the gut luminal
pathogen population between days 1–4 post infection.
Taken together, our data suggested that a population-bottleneck
explains the reduced evenness index at day 4 p.i. Equivalent
observations were made in an Nramp-positive mouse line
(129SvEv; see below), indicating that the barrier reducing the
evenness may be a general feature, independent of the mouse line
used. The gut luminal S. Tm population should encounter this
bottleneck after day one and before day 4 p.i. The 1:7000
inoculum seemed well suited for further analysis of this phenotype.
single tagged strain were plotted. Systemic spread (cfu per organ in mLN, spleen and liver) and cecal pathology on day 4 p.i. (E) confirmed a typical S.
TmWT-induced course of disease. Grey lines depict the detection limit for plating. Blue numbers indicate the median of the evenness indices of single
mice.
doi:10.1371/journal.ppat.1004557.g001
Table 1. Statistics on population evenness.
Statistics for different dilutions (Fig. 1&2) at day 4 p.i., cecum
Mann-Whitney U test p-value Summary
1:7 vs. 1:70 0.7706 ns
1:7 vs. 1:700 0.0317 *
1:7 vs. 1:7000 0.0016 **
1:70 vs. 1:700 0.0823 ns
1:70 vs. 1:7000 0.0013 **
1:700 vs. 1:7000 0.0287 *
Statistics for population evenness in fecal vs. cecal content (Fig. 2)
Mann-Whitney U test p-value Summary
day 1 p.i. 0.4127 ns
day 2 p.i. 0.5238 ns
day 3 p.i. 0.9444 ns
day 4 p.i. 0.9714 ns
Statistics for different strain backgrounds (Fig. 3&4) at day 4 p.i., cecum
Mann-Whitney U test p-value Summary
WT vs. SPI1&2 0.0002 ***
WT vs. SPI1 0.0016 **
WT vs. SPI2 0.0003 ***
WT vs. SPI2 in WT 0.4119 ns
SPI1&2 vs. SPI1 0.2222 ns
SPI1&2 vs. SPI2 0.0541 ns
SPI1 vs. SPI2 0.0732 ns
SPI2 vs. SPI2 in WT 0.0023 **
Statistics for Gr-1 depletion (Fig. 6), day 4 p.i., cecum
Mann-Whitney U test p-value Summary
PBS vs. Gr-1 depletion 0.0173 *
129 Sv/Ev vs. C57BL/6 (1:7000) 0.1066 ns
doi:10.1371/journal.ppat.1004557.t001
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The gut luminal pathogen population encounters a
pronounced bottleneck at day 2 p.i.
Next, we analyzed the time course of changes in the WITS
genetic diversity. We employed a ‘‘1:7000’’ WITS inoculum, as
the data above had indicated that this retains high evenness indices
for stool samples by day 1 and should allow sensitive detection of
changes during the subsequent days. The 1:7000 inoculum was
prepared as described above and we infected streptomycin
pretreated C57BL/6 mice (56107 cfu total, by gavage; 2
independent experiments using a total of 5 mice per group). Total
pathogen loads and the WITS in the inoculum, the stool, the cecal
content, the mLN, the spleen and the liver were quantified by
plating and rtqPCR at day 1, 2, 3 or 4 post infection (Materials
and Methods). In line with earlier results, S. Tm efficiently
colonized the feces and the cecum contents within the first day
(108–109 cfu/g; Fig. 2A,B, black bars), elicited pronounced cecum
tissue contraction and inflammation (Fig. 2D,E) and the pathogen
spread to the mesenteric lymph nodes, the spleen and the liver (S4
Figure, black bars). This verified that the infection had proceeded
as expected.
At day 1 p.i., the bacterial populations in the feces and in the
cecum content featured evenness indices almost as high as the
inoculum (medianfeces = 0.801; mediancecum content = 0.737; each
WITS present; Fig. 2 ABC). This was in stark contrast to the S.
Tm populations in the mLN, spleens and livers, which harbored
no WITS at all (S4 Figure; evenness index below detection). In line
with earlier work, this indicated that systemic dissemination is
partly restricted by a pronounced barrier and that these organs are
populated by local growth of a few ‘‘founder’’ bacteria ([6,29]; not
analyzed further in this study). In contrast, the gut luminal
population retained all WITS and the high evenness indices
indicated that S. Tm did not encounter detectable bottlenecks
during the transit through the stomach and gastrointestinal tract or
the initial colonization of the gut lumen. Based on the 1:7000
composition of the inoculum, we applied a simple binomial
selection model to estimate that the luminal S. Tm population size
never drops below 26104 cfu during this initial day of infection
(Table 2; Materials and Methods). Please note that this is an
estimate of the lower boundary (detectable with WITS-dilutions of
1:7000 and using 10 mice) and that the actual S. Tm population
size might in fact be much larger than this.
Reduced evenness indices were observed in the cecum lumen
and the feces by day 2 p.i. and evenness further declined until day
4 p.i. (medianfeces = 0.434R0.043; mediancecum content = 0.222R
0.044; Fig. 2 A, B). By day 4 p.i., most mice had ‘‘lost’’ one or
more WITS from the cecal contents and the feces (detection limit:
10 cfu/g). This indicated that some type of barrier may restrict the
gut luminal S. Tm population from day 2 on.
A simple estimate of the number of bacteria that can cross this
barrier can be done from the data on the presence or absence of
WITS at day 4 after inoculation at a dilution of 1:7000 (see
Materials and Methods). In combination with the 1:7000 dilution
experiment shown in Fig. 1D, we had a total of 10 animals
infected for 4 days. In these mice, 30 of the 70 WITS were lost
from the cecum lumen at day 4 (Fig. 1D, Fig. 2B). Assuming that
each WITS succeeds in crossing the barrier according to a
binomial process with probability 1/7000, we estimated a
bottleneck size of 5931 bacteria with a 95% confidence interval
ranging from 4242 to 8046 bacteria (Materials and Methods).
Within each animal, the WITS distribution patterns of the cecal
content and the feces were strikingly similar, in particular at days 3
and 4 p.i. (R2 = 0.854 or 0.961, respectively). Therefore, these
populations are linked and fecal samples can be used to monitor
the cecum luminal pathogen population at days 3 and 4 p.i.
Conceptually, this suggests that the cecum lumen may produce (or
seed) the pathogen population shed in the feces.
In conclusion, these data established that the gut luminal S. Tm
population is restricted by a significant barrier by day 2 p.i. and
that this bottleneck can be detected via the reduced evenness index
of the WITS-diversity. It is interesting to note that the cecum
luminal pathogen density transiently dropped at day 2 p.i. and was
as low as 105–106 cfu/g in two of the mice (Fig. 2B, mouse
#R030 and R031, black bars). Thus, a transient reduction of
the total gut luminal S. Tm population size (a ‘‘population
bottleneck’’) may contribute to the barrier restricting the gut
luminal S. Tm population. The nature of this barrier remained to
be determined.
A SPI-1 SPI-2 double mutant does not encounter a
bottleneck in the gut lumen
Next, we analyzed if mucosal inflammation contributes to the
gut luminal population bottleneck. This seemed plausible, as
inflammatory responses can (at least in tissues) eliminate pathogens
via an elaborated arsenal of antimicrobial mechanisms [26]. Gut
luminal colonization without the elicitation of mucosal inflamma-
tion can be achieved by using ‘‘avirulent’’ S. Tm mutants deficient
in the SPI-1 and SPI-2 type III secretion systems [18,19]. To this
end, we constructed ‘‘avirulent’’ WITS by P22 phage transduction
of the chromosomal tags into an invGssaV mutant (WITSSPI-1 &
SPI-2; Materials and Methods) and prepared a ‘‘1:7000’’ inoculum
by mixing with an untagged S. TmSPI-1 & SPI-2 strain as described
above. Streptomycin pretreated C57BL/6 mice were infected
(56107 cfu total, by gavage) and we analyzed pathogen loads in
the stool, the WITS diversity in stool samples, gut pathology and
pathogen loads at systemic sites (Fig. 3A). As expected, the S. Tm
mutant yielded only minimal colonization of the spleen and the
liver, reduced pathogen loads in the mLN, reduced total gut
luminal loads by day 4 p.i. and no signs of overt mucosal
inflammation by day 4 p.i. (pathoscore 2.5+/21). The WITS
evenness index in the stool was high at day 1 p.i. and only slightly
reduced by day 4 p.i. (median = 0.799R0.676; Table 1). Con-
ceivably, the slightly reduced evenness index detected at day 4 p.i.
might be attributable (at least in part) to a reduced total S. Tm
population size, as loads in the stool reached very high levels at day
1 p.i. (109–1010 cfu/g), but decreased by about 10-fold to 108–
109 cfu/g by day 4 p.i. (Fig. 3A, black bars). This is in line with
earlier work which established that, in the absence of gut
Fig. 2. WITS infections reveal severe WITS diversity loss ( = reduction in population evenness) during oral infection of C57BL/6 mice
starting at day 2 p.i. Streptomycin-pretreated C57BL/6 mice were gavaged with a mixture of 7 WITS strains in equal ratios, which were further
diluted with untagged S. TmWT to a final proportion of 1:7000. The cfu/g fecal (A) or cecal (B) content of the whole population and the individually
tagged strains were monitor daily until day 4 post infection (day 4 p. i.) of each mouse (individual mouse identifiers were plotted on the x-axis). Grey
lines depict the detection limit for plating (10 cfu/g). (C) rtqPCR analysis and selective plating of the inoculum used for infection confirmed the even
distribution of the seven tagged strain, and the 1000-fold overrepresentation of the untagged S. TmWT strain. (D) To analyze the whole cecal
population, the whole cecal content was retrieved. As the cecum shrinks in the course of S. TmWT infection [16], we monitored the total cecal weight
over time. (E) At day 4 p.i. all animals were highly inflamed as assessed by a cecal pathology score. Blue numbers indicate the median of the evenness
indices of single mice.
doi:10.1371/journal.ppat.1004557.g002
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inflammation, the re-growing microbiota can outcompete aviru-
lent S. Tm mutants lacking functional SPI-1 and SPI-2 type III
secretion systems [20]. Nevertheless, the WITS-diversity was only
slightly reduced by day 4 p.i., suggesting that the tight bottleneck
observed in wild type S. Typhimurium infections is attributable to
mucosal inflammation.
SPI-1 is more important than SPI-2 for eliciting
WITS-diversity loss
Next, we tested the individual contributions of SPI-1 and SPI-2
to WITS-diversity loss. For this we used S. Tm mutants lacking
either a functional SPI-1 TTSS (S. TmSPI-1, DinvG; strong defect
in eliciting gut inflammation at day 2 p.i.) or a functional SPI-2
TTSS (S. TmSPI-2, ssaV::cat; slight defect in eliciting gut
inflammation at day 2 p.i.), which do efficiently colonize the gut
lumen of streptomycin pretreated mice, but elicit reduced levels of
mucosal inflammation on day 2 p.i. [16,18,19], the time when the
gut luminal bottleneck is observed. The respective WITS were
constructed by P22 phage transduction thus yielding WITSSPI-1
(DinvG background; [6,34,35]) and WITSSPI-2 (ssaV::cat back-
ground; [6,35] Materials and Methods) and mice were infected
with ‘‘1:7000’’ inocula and analyzed as described for Fig. 1.
As expected, the SPI-1 mutant efficiently colonized the spleen,
the liver and the mLN and elicited moderate mucosal inflamma-
tion by day 4 p.i. (Fig. 3B). In line with earlier data, the mucosa
featured a ‘‘patchy’’ distribution of inflammatory foci typical for
the ‘‘SPI-2 mediated’’ disease [19,36] which was even at day 4 p.i.
significantly less pronounced than the inflammation elicited by
wild type S. Tm (compare Fig. 1E, 2E with Fig. 3B). The stool
loads remained high (109–1010 cfu/g) throughout the experiment
and we observed at most a slight decrease of the evenness index
(median = 0.888R0.824; Table 1).
In line with the key role of SPI-2 in systemic infection [19,37], the
SPI-2 mutant did not efficiently colonize the spleen, liver and the
mLN, but elicited mucosal inflammation (Fig. 3C). Please note that
the ‘‘SPI-1 mediated’’ mucosal inflammation elicited by this strain is
much more pronounced than the ‘‘SPI-2 mediated’’ inflammation
at day 2 p.i. [19]. In the present experiment, we analyzed the gut
inflammation at a much later time point, i.e. day 4 p.i. Here,
inflammation was much milder than the pathology elicited by wild
type S. Tm (compare Fig. 1E, 2E with Fig. 3C; [6,19]). Strikingly,
the WITSSPI-2 population featured a moderate drop of the evenness
index between days 1 and 4 p.i. (median = 0.758R0.358; Table 1).
These data are in line with the notion that mucosal inflammation
(i.e. the degree of inflammation at day 2 p.i.) may drive the WITS-
diversity loss and suggest that the grade of inflammation may dictate
(at least in part) barrier efficiency.
Mixed infection experiments verify that mucosal
inflammation is required for WITS-diversity loss
To study the effect of mucosal inflammation on strains
incapable of eliciting disease one can perform a modified version
of our mixed inoculum experiments. The inflammation elicited by
wild type S. Tm will affect all bacteria present in the gut lumen
(i.e. wild type and mutant [20,38–42]). Thus, we performed a
variant of the assay described above to verify that the bottleneck is
indeed affected by the grade of the inflammatory response (not
genetic predisposition of the S. Tm strain). In particular, we
wanted to assess the evenness index of WITSSPI-2 in the face of full
blown mucosal inflammation elicited by wild type S. Tm. This was
Table 2. Bottleneck estimates.
Bottleneck estimates for different lengths of infection (Fig. 2)
Bottleneck estimate Confidence interval Lower bound Confidence interval Higher bound
Day 1 p.i., Feces NA 25265 NA
Day 1 p.i., Cecum NA 20509 NA
Day 2 p.i., Feces 11265 7328 16752
Day 2 p.i., Cecum 5931 3656 9060
Day 3 p.i., Feces 6932 4360 10452
Day 3 p.i., Cecum 8102 5176 12102
Day 4 p.i., Feces 6932 4360 10452
Day 4 p.i., Cecum 5931 4242 8046
Bottleneck estimates for different inflammatory conditions (Fig. 3&4)
Bottleneck estimate Confidence interval Lower bound Confidence interval Higher bound
SPI1 deficient mutant NA 20509 NA
SPI2 deficient mutant NA 22809 NA
SPI1&2 deficient mutant NA 23727 NA
SPI2 mutant diluted in WT 7690 5098 11137
Bottleneck estimates for Gr-1 depletion (Fig. 6)
Bottleneck estimate Confidence interval Lower bound Confidence interval Higher bound
PBS control 5193 3287 7761
Gr-1 depletion NA 20509 NA
Bottleneck estimates and 95% confidence intervals for different inflammatory conditions and during different lengths of inflammation.
NA indicates that there is no proper estimate. This happens mainly in the cases where no WITS are lost. In these cases only a lower bound is applicable.
doi:10.1371/journal.ppat.1004557.t002
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Fig. 3. WITS diversity loss is inflammation-dependent. Streptomycin-pretreated C57BL/6 mice were orally infected with a WITS cocktails in the
dilution 1:7000 in different strain backgrounds: (A) S. TmSPI-1 & SPI-2, (B) S. TmSPI-1 and (C) S. TmSPI-2 and WITS compositions throughout the infection
process were monitored by rtqPCR. For each conditions, organ loads and cecum pathology at day 4 p. i. were monitored. Grey lines depict the
detection limit for plating (10 cfu/g for feces, cecal content and mLN, 20 cfu/organ for spleen and 60 cfu/organ for liver). Blue numbers indicate the
median of the evenness indices of single mice.
doi:10.1371/journal.ppat.1004557.g003
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of particular interest, as WITSSPI-2 can colonize the gut lumen, but
fails to efficiently grow in the mucosal lamina propria and at
systemic sites [19]. Thus, using WITSSPI-2 would help to exclude
possible re-seeding from such sites and therefore allow focusing on
the gut luminal pathogen population. To this end, we mixed
WITSSPI-2 with an excess of wild type S. Tm [6,38]. Streptomycin
pretreated C57BL/6 mice were infected for 1 or 4 days with a
‘‘1:7000’’ inoculum composed of WITSSPI-2 and untagged S.
TmWT and we analyzed the infection as in Fig. 1. Pathogen organ
loads (i.e. WITSSPI-2 plus untagged S. TmWT) and cecum
pathological scoring confirmed an overall ‘‘wild type’’-like
intestinal disease progression during this mixed infection experi-
ment (Fig. 4A,B, compare to Fig. 2E; black bars). Remarkably, in
this experiment, the WITSSPI-2 evenness index dropped much
further than in infections performed with WITSSPI-2 alone by day
4 p.i. (median = 0.06; Fig. 4A, compare to Fig. 3C). In fact, the
evenness index at day 4 p.i. was strikingly similar to that of wild
type WITS (median = 0.033 and 0.044; see Fig. 1D and 2A,B;
Table 1). We therefore conclude that the bottleneck is determined
by the degree of inflammation, not by the genetic background of
the tagged subpopulation.
The size of the cecum luminal S. Tm population is
diminished at day 2 post infection
Reduced WITS-evenness can be explained by a drastic
reduction in the cecal S. Tm population size and a subsequent
(oligo-clonal) regrowth of the population. In fact, transient
reductions of the cecal and fecal population densities at day 2
Fig. 4. Severity of inflammation, not genetic background of the tagged strains, determines WITS diversity loss. (A) To exclude a strain-
intrinsic property of the SPI-2 WITS to be responsible for the decrease in WITS diversity loss observed in the S. TmSPI-2 background, we tested a
chimeric situation in which inflammation was caused by S. TmWT but WITS-tags were in a SPI-2 deficient background. Experiments were performed
using a WITS cocktail in a dilution of 1:7000. Grey lines depict the detection limit for plating (10 cfu/g). Blue numbers indicate the median of the
evenness indices of single mice. (B) Organ loads and cecum pathology at day 4 p.i. confirmed the ‘‘WT-like’’ severity of the infection.
doi:10.1371/journal.ppat.1004557.g004
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p.i. have been observed repeatedly (though never followed up in
detail), over the past decade ([20]; Fig. 2A,B). To specifically
analyze the population size at this critical time point, we
monitored changes in cecum luminal S. Tm population size by
sacrificing S. TmWT-infected mice at day 1 and at day 2 p. i. and
by determining the respective pathogen loads. In line with earlier
data, the mice featured moderate colitis by day 1 and pronounced
colitis by day 2 p.i. (Fig. 5B). The pathogen densities in the cecum
lumen were high at day 1 p.i. (<109 cfu/g), but dropped
significantly by day 2 (median = 36107 cfu/g, Fig. 5A). Strikingly,
the gut luminal pathogen density featured pronounced animal-to-
animal variation. In some animals, the pathogen density dropped
down to 36105 cfu/g. Without further information, these data
cannot tell whether the dip in the gut luminal pathogen density is
more pronounced in some animals than in others. Alternatively,
equivalent dips may occur in all mice however with slightly
different kinetics. Nevertheless, the data suggests that a transient
dip in the cecum luminal population size may contribute to the
drop in WITS evenness at least in some of the mice.
If pathogen-triggered inflammation was responsible for the dip
at day 2 p.i., cecal S. Tm densities should remain higher in cases of
reduced mucosal inflammation. To test this hypothesis, we
infected mice with S. TmSPI-2 and compared cecal population
sizes at day 1 and day 2 p. i. Indeed, under these conditions cecal
S. Tm loads remained equally high from day 1 to day 2 (Fig. 5).
Taken together, our observations suggest that S. TmWT
triggered inflammation can inflict a transient population bottle-
neck at day 2 p. i. and that this contributes at least in part to the
reduced evenness index, observed in our WITS experiments.
Depletion of Gr1+-cells alleviates the bottleneck
Thus far, our data suggested that the grade of the mucosal
inflammation is a key determinant of the bottleneck at day 2 p.i.
However, the mechanisms explaining this barrier to infection
remained to be identified. One hallmark of S. Tm induced
inflammation is the tissue infiltration by granulocytes, their
transmigration into the gut lumen and the formation of
characteristic crypt abscesses [15]. As granulocytes can attack
bacteria by bactericidal mechanisms such as phagocytosis, release
of antimicrobial substances and formation of neutrophil extracel-
lular traps (NETs) [43], they might contribute to the gut luminal
bottleneck. However, to the best of our knowledge, it has not been
assessed previously, whether granulocytes can have bactericidal
activity upon transmigration into the gut lumen.
To test if granulocyte-mediated killing contributes to the gut luminal
bottleneck, we employed a cell depletion strategy. Initially, we depleted
granulocytes during S. TmWT infection using an a-Gr1 antibody
(100 mg i.p., once per day; Materials and Methods; Fig. 6A) which
binds to Ly6G on neutrophilic granulocytes (PMN) and to Ly6C, a
marker expressed on neutrophils and on dendritic cells, some
subpopulations of lymphocytes and some monocytes [44]. For this
experiment, we used 129SvEv mice (Nramp/slc11a1+/+) as their
monocytes can control S. Tm growth at systemic sites much more
efficiently than those from slc11a12/2 C57BL/6 mice [45,46]. This
allowed infecting Gr1+-depleted mice for 4 days without compromising
the viability of the animal (Fig. 6A).
First we analyzed the effect of granulocyte depletion on the
cecum luminal pathogen density at day 2 p.i. Gr1+-cell-depleted
mice, and PBS-treated control animals were pretreated with
streptomycin and infected for 1 or 2 days with S. TmWT. The
efficiency of granulocyte depletion was verified by flow cytometry
(CD45+, Ly6G+, Ly6C+ cells; Fig. 6B) of murine blood. The
detailed effect of Gr-1 neutralization on inflammatory myeloids in
the cecal mucosa of 129SvEv mice revealed that the procedure
depleted not only granulocytes, but also other phagocyte
populations (S5 Figure, S1 Text). Pathogen loads in the mLN,
the spleens and the livers did rise in both groups by 10–100 fold
between day 1 and day 2 p.i. We detected (at most) slightly
elevated tissue loads in the Gr1+-depleted mice, while both groups
featured equivalent S. TmWT loads in the cecal lumen at day 1 p.i.
(Fig. 6C). Strikingly, the cecum luminal pathogen loads remained
high at day 2 p.i. in the Gr1+-depleted mice, but plummeted in the
PBS controls. This went along with reduced gut luminal
granulocyte (CD18+) numbers in the Gr1+-depleted mice
(Fig. 6D,E) and suggested that granulocytes may indeed affect
the bottleneck.
Fig. 5. Decrease in cecal population size between day 1 and day 2 p.i. only occurs during S. TmWT induced inflammation, but not
during inflammation in a SPI-2 deficient background. Streptomycin-pretreated C57BL/6 mice were orally infected with S. TmWT or S. TmSPI-2,
respectively. Mice were sacrificed at day 1 or day 2 p.i. and bacterial population size (A) and cecum pathology at the day of sacrifice (B) were plotted.
ns = not significant (P$0.05), * P,0.05, ** P,0.01, *** P,0.001; Mann-Whitney U test.
doi:10.1371/journal.ppat.1004557.g005
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A second experiment was performed to assess effects on the
WITS evenness index. Gr1+-depleted mice, and PBS-treated
control animals were pretreated with streptomycin and infected for
4 days with a ‘‘1:7000’’ inoculum of S. TmWT WITS as described
for Fig. 2. In line with earlier work, the Gr1+-depleted mice
featured increased organ loads in the mLN, the spleens and the
livers [47]. This verified that granulocytes indeed significantly limit
systemic infection. In contrast, cecum luminal total S. TmWT
densities did not differ between both groups (Fig. 6F, left panel,
black bars). Strikingly, the WITS evenness index remained much
higher in the Gr1+-depleted mice, as compared to the PBS
controls (Fig. 6F, Table 1). In a complementary, yet more specific
strategy, we applied a combination of a-Ly6G and a-G-CSF
antibodies to selectively reduce granulocytes but spare monocytes
from depletion [48,49]. Again, the depleted animals featured
higher WITS evenness indices than the control group treated with
the respective isotype controls of both antibodies (S6 Figure, S1
Text). These data supported our hypothesis that Gr1+ cells (mainly
granulocytes) form a major bottleneck for the gut luminal S. Tm
population by day 2 p.i. However, these results raised the question
whether this outcome is a direct effect of the bactericidal activity of
granulocytes (e.g. NO/ROS production) or an indirect effect (e.g.
reduction of granulocyte-released cytokines or antimicrobial
proteins). First, we examined WITS diversity loss in Nos2-deficient
mice to clarify the requirement of inflammation-mediated NO
production in reducing luminal S. Tm. As Nos2 was shown to be
dispensable for controlling S. Tm during the initial days of
infection [50], we hypothesized that the Nos2-deficient mice
should restrict gut luminal S. Typhimurium loads as efficiently as
the wild type animals. In line with this, the WITS evenness indices
in Nos22/2 mice and the littermate controls did not differ at day 3
p.i. (S7A Figure, S2 Table) suggesting that NO is not the
predominant cause for the WITS diversity loss.
Next, we tested the contribution of oxidative burst in the
reduction of WITS evenness. As NADPH-oxidase is a key
antimicrobial factor of granulocytes [43] at systemic sites and in
the intestinal tissue [51] and as these cells do transmigrate in large
numbers into the lumen of the inflamed gut, we speculated that
Cybb2/2 mice might be incapable of restricting gut luminal
pathogen loads in the inflamed gut. Strikingly, WITS evenness in
the NADPH-oxidase deficient (Cybb2/2) mice at day 3 p.i. was
increased compared to a heterozygous control group (S8A Figure,
S2 Table) pointing to a possible involvement of direct ROS-
mediated killing to the bottleneck effect. However, interpretation
of WITS analysis in the Cybb2/2 mice is limited by a high S. Tm
colonization at systemic sites up to levels where WITS-tagged
strains are found systemically (S8B Figure). As possible re-seeding
events of these strains into the gut lumen may compromise the
unequivocal interpretation of our WITS-diversity analysis, these
results should be taken with caution.
Taken together, the gut luminal S. Tm population bottleneck is
mostly caused by granulocytes, possibly via a direct ROS-
mediated killing mechanism. However, our data do not exclude
the contribution of additional factors to this bottleneck effect.
Discussion
To identify barriers limiting S. Tm in the gut lumen, we have
performed mixed inoculation experiments. During the first day,
the pathogen density rose to <109 cfu/g in the large intestinal
lumen without encompassing obvious bottlenecks. In the case of
wild type S. Tm infection, cecum colonization was accompanied
by pronounced mucosal inflammation which arises during the
first day (8–12 h p.i.; [15,52]) and lasts for four days (or longer;
[46,53]). By day 2 p.i., the inflammatory response dramatically
reduces the gut luminal pathogen density. This inflammation-
inflicted, granulocyte-dependent bottleneck transiently restricts
the gut luminal S. Tm population to about 6000 cfu. By days 3
and 4, the pathogen density rises again to <109 cfu/g of gut
content. These data establish that mucosal inflammation can
represent a barrier limiting the gut luminal colonization by the
pathogen.
Our findings significantly extend earlier work on S. Tm growth
in the lumen of the inflamed gut. That earlier work had indicated
that the pathogen subverts the inflammatory milieu in the gut
lumen for its own advantage, i.e. for outcompeting the resident
microbiota (reviewed in [15,54,55]). Granulocytes infiltrating the
inflamed mucosa and transmigrating into the gut lumen are
thought to contribute in several different ways i.e., by i) providing/
regenerating terminal electron acceptors (tetrathionate, nitrate)
used by S. Tm, thereby fuelling anaerobic respiration and fast
growth of the pathogen (not the commensals, which are mainly
fermenters [24,25]); by ii) releasing lipocalin-2, an antimicrobial
peptide blocking siderophore-mediated iron acquisition by E. coli.
Interestingly, S. Tm is endowed with the iroBCDEN variant of
such system which can bypass the lipocalin-2-mediated restriction
[23]; by iii) releasing calprotectin which sequesters Zn2+, an
essential micronutrient, from the gut lumen. This restricts
microbiota growth, while S. Tm can bypass this restriction using
a high affinity zinc transporter (znuABC; [22]). Furthermore, S.
Tm is endowed with enzymes inactivating PMN-derived reactive
oxygen and nitrogen compounds [56–58]. Overall, these earlier
findings indicated that granulocyte activity (and mucosa inflam-
mation in general) foster pathogen growth in the intestine and
prevent growth of the resident microbiota. However, the
quantitative contribution of inflammation-mediated fuelling versus
restriction of S. Tm growth in the gut lumen had remained
unclear. Our findings demonstrate that the gut luminal S. Tm
population is highly vulnerable to the inflammatory response in
particular at day 2 p.i. We conclude that the size of the pathogen
population in the inflamed gut is controlled by a fine balance
between inflammation-fuelled pathogen growth (and competition
against resident microbiota) and inflammation/granulocyte-inflict-
ed losses to the pathogen population.
Fig. 6. Depletion of Gr1+- cells reduces WITS diversity loss and prevents the cecal population crash between day 1 and day 2 p.i. (A)
Schematic overview of the experimental setup. Starting with streptomycin-pretreatment one day prior to infection with the S. TmWT WITS cocktail in a
dilution of 1:7000, Gr1+-cells (mostly neutrophilic granulocytes) were depleted by daily i.p. injection of 100 mg of anti-mouse-Gr1-antibody. The
control group was injected with an equal volume of PBS. (B) Successful reduction in Ly6C+ Ly6G+ cells in the murine blood was verified daily using a
flow cytometry assay. A representative blot is given in panel B. (C) The cecal S. Tm population size was monitored in the Gr1+-cell depleted mice and
the control group and organ loads and cecum pathology of respective animals were assessed. (D) CD18 immunofluorescent staining of cecal section
from Gr1+-cell depleted mice and PBS treated control groups confirmed reduction of granulocytes in the course of the experiment. Scale bars: 50 mm
(E) Quantification of luminal granulocytes from tissue sections. (F) At day 4 p.i. animals were sacrificed and the population composition in cecal
contents were analyzed by rtqPCR. Organ pathogen loads and cecum pathology at day 4 p.i. indicate systemic pathogen spread and high intestinal
inflammation. ns = not significant (P$0.05), * P,0.05, ** P,0.01, *** P,0.001, Mann-Whitney U test. Grey lines indicate detection limits. Blue
numbers indicate the median of the evenness indices of single mice.
doi:10.1371/journal.ppat.1004557.g006
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How many S. Tm cells survive the bottleneck in the gut lumen?
Our best estimate is that 6000+/22000 bacteria survive this dip at
day 2. This value is obtained from a simple binomial selection
model fitted to the data on the detectability (presence/absence) of
WITS at day 4 for the 1:7000 dilution. This model assumes
that there are no fitness differences between WITS and that
the population bottleneck is effective for only a short time.
The classical cfu-plating revealed reduced, but highly variable
pathogen population sizes at day 2 p.i. (median = 26106 cfu/g). In
a few mice, we detected as few as 36105 cfu/g of cecum content
by day 2 p.i. This corresponds to a total population size of 15000
bacterial cells, considering that the infected cecum (tissue+lumen)
has a total volume of no more than 200 ml, and that the cecal
luminal volume might range at approx. 50 ml at this stage. The
high variance of the cfu-data measured at day 2 p.i. and the
similarity of the evenness-indices across animals suggest that the
pathogen population may be reduced for no more than a few
hours before net re-growth occurs. Using 24 h sampling intervals,
classical cfu-plating would therefore miss the low in most mice, in
particular if the time-course would differ from animal to animal.
Therefore, we conclude that the bottleneck allows the survival of
just 6000 bacteria. Thus, the mucosal inflammation is a strikingly
efficient host defense, reducing the total cecum luminal population
by about 105–106 fold (108 cfu per cecum at day 1 p.i. to 6000
bacteria by day 2). This is almost as efficient as chemical
disinfectants (defined as reducing bacterial survival by $106-fold;
[59]) and far more effective than many other barriers, e.g. the
IFNc or inflammasome mediated restriction of systemic spread
(<10-fold restriction by day 2 p.i.; [60,61]) or the gut luminal
growth defect inflicted by adaptive sIgA response directed against
the LPS O-sidechain (<10-fold; [53,62]) limiting S. Tm loads at
different stages of an infection. In conclusion, the mucosal
inflammation severely reduces the gut luminal S. Tm population
by day 2 p.i. However, this is not quite sufficient to yield sterilizing
protection and to prevent subsequent pathogen-regrowth.
In this work, the importance of granulocytes in controlling S.
Tm within the gut lumen is re-emphasized and extended. Already
in the early studies of streptomycin pretreated mice, neutrophil
infiltration was detected in the cecal mucosa by 10 h p.i. [63].
Similarly, granulocytes are prominent in the infected mucosa of
cows and man [64,65], they transmigrate into the gut lumen and
form the archetypical ‘‘crypt abscesses’’, i.e. densely packed
clusters of granulocytes located within the intestinal crypts [66–
69]. By extension, these observations suggest that granulocyte-
mediated growth and restriction might be of general importance
also in other hosts including the human patient.
During the first day of infection, granulocytes might also serve
as a host cell permissive for intracellular growth (or at least
survival) of the pathogen. In the streptomycin mouse model, gut
luminal neutrophils harbored significant numbers of S. Tm by
20 hours p.i. and most of these bacterial cells were viable, as
judged from the expression of iroBCDE- and ttss-2 driven GFP
reporters [70]. Other studies have also indicated that S. Tm can
survive in murine neutrophils [70–72]. The lack of a bottleneck
during the first day of infection would be in line with this. Our
data suggest that the barrier detected by day 2 p.i. is attributable to
some quantitative or qualitative change in the inflammatory
response and/or the granulocyte activity, e.g. by modulating
NADPH-oxidase dependent defenses. Identifying the underlying
mechanism controlling the granulocyte-inflicted bottleneck will be
of interest for future work and might identify strategies for
bolstering the gut luminal barrier. Still, our data suggest that
pronounced granulocyte migration into the gut lumen can have
detrimental effects on the S. Tm population, at least by day 2 p.i.
Furthermore, our data provide first hints that ROS might play a
central role in decimating luminal S. Tm, despite of the low
oxygen-availability in the gut lumen and the fact that S. Tm
expresses three catalases and three periplasmic Cu,Zn superoxide
dismutase enzymes [73]. Thus, the interaction of S. Tm with
granulocytes in the gut lumen is clearly important, but more
complex than previously anticipated.
In summary, investigating mixed inocula allows precious
insights into colonization strategies and host defenses limiting
infection. The population bottlenecks identified by such approach-
es may represent attractive points for therapeutic interventions, as
pathogen populations are already reduced to a minimum.
Materials and Methods
Bacterial strains
The wild type strain SB300 is a clone of S. Tm SL1344 and the
SPI-1 and SPI-2 deficient mutant strains (S. TmWT, S. TmSPI-1, S.
TmSPI-2), as well as their isogenic tagged strains have been
described previously [5,6,34,35,74]. WITS-tags were introduced
into S. TmSPI-1 & SPI-2 (SL1344 invGssaV; [17] and into S.
TmSPI-2 (SL1344 ssaV::cat; [35]) by P22 phage transduction and
subsequent selection on kanamycin. The presence of the correct
WITS-tag was confirmed by PCR using tag-specific primers (see
S1 Table).
Mouse lines
Wild type C57BL/6 mice were bred and kept under specified
pathogen free (SPF) conditions in individually ventilated cages at
the Rodent Center RCHCI (ETH Zurich). They harbor a
complex microbiota and are called ‘‘conventional’’ mice. For
reliable and efficient infection with S. Tm, streptomycin pretreat-
ment of these mice was performed in order to overcome
colonization resistance in all experiments described herein [16].
129 Sv/Ev mice are Nramp1(+/+) (Slc11a1(+/+)) mice which can
control systemic S. Tm infection with low bacterial loads at
systemic sites but develop acute S. Tm colitis upon streptomycin
pretreatment [46]. 129 Sv/Ev mice are specified pathogen free
animals with a complex microbiota. Cybb2/2 (B6.129S-Cy-
bbtm1Din/J; C57BL/6 background) and Nos22/2 (B6.129P2-
Nos2tm1Lau/J; C57BL/6 background) were bred at the Rodent
Center HCI (ETH Zurich, Switzerland). Both mouse lines have
been described previously [75,76].
Animal infection experiments
Animal infection experiments were performed in 8 to 12 week
old mice as described previously [16]: C57BL/6 mice or 129 Sv/
Ev mice were pretreated with 20 mg streptomycin 24 hours prior
to infection. For infection, bacteria were grown for 12 h in 0.3 M
NaCl supplemented LB medium containing the appropriate
antibiotic(s), diluted 1:20 and sub-cultured for 4 h in the same
medium without supplementation of antibiotics. Tagged and un-
tagged strains were mixed as indicated, washed twice with PBS
and mice were infected with 56107 bacteria by gavage. Each
animal was kept in a single cage to avoid transmission between
mice. Animals were sacrificed at day 4 p.i. by cervical dislocation.
Freshly collected fecal pellets or whole cecal content were
harvested, homogenized in 500 ml PBS with steel balls in a Tissue
Lyser (Qiagen) for plating to determine the total population size.
250 ml of homogenized feces or cecal content were used to
inoculate an over night culture in LB supplemented with 50 mg/ml
kanamycin to select for tagged strains. Bacteria from 1 ml of this
over night culture were harvested and frozen for genomic DNA
extraction. HE-staining of cryo-embedded tissues and subsequent
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pathoscoring for granulocyte infiltration was performed as
described previously [16]. To test for selection of beneficial
mutations which might explain the variation in the subpopulations
at day 4 p.i., we re-isolated dominant WITS-tagged bacteria from
cryo-embedded tissues by plating on kanamycin. Untagged strains
were isolated in the same way, but were selected for growth on
streptomycin and remained kanamycin sensitive. Competitive
infection experiments to test for increased fitness of re-isolated
strains were performed by infecting streptomycin-pretreated mice
with equal amounts of S. TmWT or a WITS-tagged S. TmWT
strain and the isolates. By selective plating, population sizes of both
were determined and a competitive index was calculated by
dividing the ratio of the isolate to the background strains by the
ratio of both strains in the inoculum.
WITS quantification
Genomic DNA from enrichment cultures was isolated with the
QIAamp DNA Mini Kit (Qiagen, Cat. NO. 51306). rtqPCR
analysis with FastStart Universal SYBR Green Master (Roche) was
performed using primers and temperature profiles as described
previously [5]. The population size of each tagged strain was
calculated by multiplying the number of kanamycin resistant cfu/g
recovered S. Tm with the ratio of WITS determined by rtqPCR.
Depletion of Gr-1+-cells
The monoclonal anti-Gr1 antibody NIMP-R14 is highly specific
for the murine epitopes Ly6G and Ly6C and was shown to selectively
deplete mouse neutrophils [77]. For depletion of Gr-1+-cells during S.
TmWT infection, we injected 100 mg of anti-Gr1 i.p. on a daily basis,
starting 24 h prior to infection. Granulocyte depletion was assessed
daily by analysis of peripheral blood (and lamina propria after
sacrificing the mice) in a flow cytometry assay using the following
staining antibodies: anti-CD11b-PECy7 (clone M1/70), anti-Ly6C-
FITC (clone AL-21), anti-Ly6G-450V (clone 1A8) and anti-CD45.2-
APC (clone 104). NIMP-R14 hybridoma was a kind gift of Dr. Nancy
Hogg (Cancer Research UK, London, U.K.) and antibodies for flow
cytometry were purchased from BioLegend.
Immunofluorescence microsopy of fixed tissue
Cecal tissues were recovered, fixed for 5 h in 4% paraformal-
dehyde/4% sucrose, saturated in PBS/20% sucrose (overnight,
4uC), embedded in OCT medium (Sakura, Torrance, CA), snap-
frozen in liquid nitrogen and stored at 280uC. Cryosections
(20 mm) were air-dried, rehydrated with PBS and permeabilized
with PBS/0.5% Triton X-100. Unspecific binding was blocked
with PBS/10% Normal Goat Serum. The tissue sections were
immunostained using rat-anti-mouse-CD18 (clone M18/2, Biole-
gend, (1:300)). Goat-anti-rat-Cy3 (112-165-167, Jackson, 1:200)
was used as a secondary antibody. DNA was stained with DAPI
(SIGMA Aldrich) and F-actin was stained using AlexaFluor647-
conjugated phalloidin (Molecular probes). Sections were subse-
quently mounted with Mowiol (Calbiochem). Imaging was
performed using a Zeiss Axiovert 200 m microscope equipped
with 106–1006 objectives, a spinning disc confocal laser unit
(Visitron) and parallel Evolve 512 EMCCD cameras (Photo-
metrics). CD18+ cells were enumerated in 406 field of vision in
several non-consecutive sections per mouse in a blind fashion and
the average number of CD18+ cells were compared between
experimental groups.
Statistical analysis
The exact Mann-Whitney U test was performed using the
software Graphpad Prism Version 6.0 for Windows (GraphPad
Software, La Jolla California USA, www.graphpad.com). P values
of less than 0.05 (two-tailed) were considered as statistically
significant. * P,0.05, ** P,0.01, *** P,0.001.
Evenness indices were calculated as described [31]. In cases
where none of the seven WITS tagged strains were detectable any
more, no evenness index was applicable and the corresponding
mice were ignored for determination of the median evenness and
the comparison between evenness indices in Table 1.
It should be noted that the 1:7 inoculum also yielded a
somewhat reduced evenness by day 4 p.i. (median = 0.528). This
cannot be explained by technical error when using our simple
population model and may suggest that a second, so far
unidentified process may affect the gut luminal S. Tm population.
However, this effect was much smaller than the WITS-diversity
loss observed with the 1:7000 inoculum. In the present paper, we
have decided to focus on the latter phenomenon.
Estimation of the bottleneck size
We estimated the bottleneck size using the data on WITS loss
after their inoculation at the lowest dilution of 1/7000. Let w be
the number of WITS, which, in our experiments, was always
w = 7. Further, let m be the number of mice in a given treatment
group. Then we have a total of mw WITS in that treatment group.
Lastly, let x denote the number of WITS that cannot be recovered
across all mice. In the control group for example, 30 of the 70
WITS in the 10 mice were undetectable at day 4, and we thus
have w = 7, m = 10, x = 30.
The procedure to estimate the bottleneck size is based on the
simplest possible model of this process: binomial selection. We
assume that during the bottleneck, B bacterial cells are selected. B
is the bottleneck size, i.e. the number of bacteria that are able to
traverse the bottleneck. The probability of selecting a certain
WITS is determined by its dilution, d = 1/7000. Not selecting this
WITS happens with a probability of p0 = (12d)
B. We can
construct a log-likelihood for loosing x out of mw WITS by
bottlenecking: , = xlnp0+(mw2x)ln(12p0). Maximizing this log-
likelihood yields the maximum likelihood estimates for the
bottleneck size listed in Table 2. To calculate confidence intervals
for the estimates we used the profile likelihood [78]. If all or no
WITS are lost in a treatment group, only upper or lower bounds of
the bottleneck size can be calculated, respectively.
Ethical statement
All animal experiments were reviewed and approved by the
Kantonales Veterinäramt, Zürich (license 223/2010) and are
subject to the Swiss animal protection law (TschG).
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S1 Figure Schematic overview of the experimental
setup to investigate WITS diversity loss in mouse models
for oral S. Tm infections. (A) Mice were infected with a
mixture of 7 individually tagged S. Tm strains (WITS = wild type
isogenic tagged strains) in equal proportions. S. Tm population
composition in feces and cecal contents of these mice were
monitored by collecting samples, selectively growing the tagged
strains based on their antibiotic resistance marker, isolating gDNA
of the tagged population and quantifying each of the tagged strains
by rtqPCR using tag-specific primers. (B) WITS proportions after
the infection experiment indicate whether tagged strains are
randomly lost. WITS diversity was measured by an evenness
index, ranging from 1 (totally even) to 0 (totally uneven). (C)
Dilution of the tagged strains with the untagged, isogenic
background strain enhances the sensitivity of WITS diversity loss
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detection, resulting in a more variable WITS composition with a
random dominant tagged strain.
(TIF)
S2 Figure Enrichment culturing does not bias WITS
analysis. To test whether culturing of cecal/fecal samples
to enrich for the WITS-tagged subpopulation biases WITS
composition analysis, we performed serial dilution of the tagged
strains, inoculated overnight cultures and analyzed WITS
population evenness after incubation. The horizontal grey line
depicts the detection limit. Blue numbers indicate the evenness
index/the median of the evenness indices of each replicate.
Starting at inoculation sizes as low as 20 bacteria, WITS evenness
decreases due to sampling effects.
(TIF)
S3 Figure Selective sweep is not sufficient to account for
the WITS diversity loss shown in Fig. 1 and Fig. 2. To
exclude that fitness-enhancing mutants might confound our
analysis, we performed competitive infection experiments with
clones re-isolated at day 4 p.i. Selective sweep by such mutants with
higher fitness than wild type S. Tm may potentially result in the loss
of WITS-diversity shown in Fig. 1. Earlier work has shown that S.
Tm mutants with increased fitness can indeed be selected during
within-host evolution [39]. Occurrence of beneficial mutations is a
random process attributable to the standard mutation rate
(approximately 0.3–1.561029 mutations per base pair per gener-
ation for S. Tm LT2 [79]) that may result in particular fit clones
which can outcompete (exclude) the rest of the population.
Beneficial mutations could have been selected in the untagged
populations of S. Tm or in the WITS-tagged subpopulations. To
test this hypothesis we isolated the most frequent clones from stool at
day 4 p.i. Such clones should be representative of the surviving
population and might therefore harbor beneficial mutations. We
isolated representatives of the untagged population (‘‘untagged’’)
and of the tagged population (‘‘tagged’’). To test their relative
fitness, streptomycin pretreated C57BL/6 mice were infected with a
1:1 mixture of the re-isolate and of the isogenic original S. Tm strain
(56107 cfu total, by gavage) and we analyzed pathogen loads in the
cecal content at day 4 p.i. by plating. We compared the fitness of the
isolate to a ‘‘control’’ strain, i.e. a naı̈ve WITS strain as used for
inoculum preparation in our infection experiments. Five out of six
re-isolates had competitive index (C.I.) values of 1, indicating that
they featured equivalent fitness than the wild type strain (and a naı̈ve
‘‘control’’ WITS strain). Thus, selective sweep cannot explain the
loss of WITS-diversity in the experiment shown in Fig. 1 and Fig. 2.
In conclusion, these data support that a bottleneck in the pathogen
population might reduce the WITS diversity in the gut lumen of S.
TmWT infected mice. C.I. = ratio of the isolate to the background
strains in stool at day 4 p.i. divided by the ratio of both strains in the
inoculum. The grey line represents a C.I. of 1 indicating that the
naı̈ve background strain and the isolate are equally fit.
(TIF)
S4 Figure Supplementary information on the experi-
ment depicted in Fig. 2. S. Tm loads of the untagged and
tagged strains were monitored in the mLN (A), spleen (B) and
liver (C) of mice infected with the mixture of the WITS strains in
an equal ratio, diluted by untagged S. TmWT to a final dilution of
each of the tagged strains of ‘‘1:7000’’. This pattern of
colonization is in line with previous work. There are two
interesting observations that should be pointed out. First, the
pathogen loads of livers and spleens differed significantly from
animal-to-animal at day 1 p.i. In some cases, the loads were even
higher than at days 2 p.i. This would be in line with earlier
observations indicating that the systemic spread may occur in two
separate waves. During the first hours of an orogastric infection
work in S. Tm and Yersinia infection models identified initial
(and quite random) ‘‘waves’’ of bacteria leaving the gut, but
failing to establish stable populations at systemic sites [3,80]. A
second wave of bacteria is thought to colonize these sites starting
by day 2 p.i. In our case, this would correspond to the steady
increase in spleen and liver organ loads by about 1.5 log10 per
day from day 2 to day 4 p.i. Second, it is interesting to note that
no animal harbored any WITS in the mLN, spleen or the liver.
This is in line with our previous work [6,29] and indicates that
these sites are seeded by much fewer than 1000 bacteria
(estimated 385 bacteria) and that the few ‘‘initial colonizers’’
have been replicating on site to fill the respective niche. Grey
lines depict the detection limit for plating.
(TIF)
S5 Figure Supplementary information on experiments
depicted in Fig. 6. Anti-Gr-1 neutralization efficacy on
inflammatory myeloids in the cecal mucosa. (A–B) PBS or
anti-Gr-1-treated 129 Sv/Ev mice were infected with S. TmWT
and sacrificed at the indicated time points. The number of
granulocytes, as well as inflammatory monocytes was deter-
mined in the cecal mucosa during infection (S1 Text). (A)
Gating strategy to identify the denoted myeloid subsets.
Frequency on plots represent percentage of either CD45+
CD32 CD11b+ live cells (upper panel) or CD45+ MHCII2 live
cells (lower panel). (B) Number of Siglec-F+ Ly6G2 eosinophils,
Siglec-F2 Ly6G+ neutrophils and CD11b+ Ly6Chi monocytes
are plotted at day 1 and 2 post infection. Of note, quantification
in B are complementary data to Fig. 6C, D and E from the same
ceca.
(TIF)
S6 Figure Pilot experiments to specifically deplete
granulocytes by injection of anti-G-CSF and anti-Ly6G
antibodies confirm that WITS diversity loss is granulo-
cyte-dependent. (A) Schematic overview on the experimental
setup to specifically deplete granulocytes (S1 Text). (B) Flow
cytometry of blood derived from the G-CSF/Ly6G-depleted 129
Sv/Ev mice and the control group (treated with isotype control
antibodies) confirm specific depletion of granulocytes, while
monocytes are still present. (C) WITS analysis of the fecal (day 1
p.i.) and cecal (day 3 p.i.) S. Tm population in G-CSF/Ly6G
depleted mice compared to the control group. Grey lines indicate
the detection limit for plating (10 cfu/g) and blue numbers
indicated the median of the evenness indices of single mice.
(TIF)
S7 Figure Deficiency in host-derived NO does not
alleviate WITS diversity loss. Nos2-deficient mice and their
heterozygous littermates were infected with a cocktail of the 7
WITS strains in a 1:7000 dilution. For each mouse (mouse
identifiers on x-axis) the cfu/g fecal (day 1 p.i.) and cecal content
(day 3 p.i.) (A) and the cfu per mLN, liver and spleen (B) of the
total population and the individual WITS strains are depicted.
Grey lines indicate the detection limit for plating (10 cfu/g for
feces, cecum and mLN, 20 cfu/organ for spleen, 60 cfu/organ for
liver) and blue numbers indicate the median of the evenness
indices of single mice. (C) Cecal pathological scoring at day 3 p.i.
indicated intestinal inflammation. (D) Analysis of the inocula used
for the experiments depicted in this figure and in Fig. S8 verified a
1:7000 ratio of each of the tagged strains.
(TIF)
S8 Figure ROS formation might partially explain the
WITS diversity loss in the lumen of the inflamed gut.
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Cybb-deficient mice and a heterozygous control group were
inoculated with a mixture of the 7 WITS strains in a 1:7000
dilution (see analysis of inoculum in panel D of suppl. Fig. S7).
The composition of the S. Tm population in fecal (day 1 p.i.) and
cecal content (day 3 p.i.) (A), as well as in mLN, spleen and liver
(B) is shown for each animal (mouse identifiers are plotted on the
x-axis). Please note that S. Tm colonization at systemic sites is
one to two orders of magnitude higher in the Cybb2/2 mice
compared to the heterozygous control group. Grey lines indicate
the detection limit for plating (10 cfu/g for feces, cecum and
mLN, 20 cfu/organ for spleen, 60 cfu/organ for liver) and blue
numbers indicate the median of the evenness indices of single
mice. (C) Analysis of cecal sections at day 3 p.i. by pathoscoring
revealed severe intestinal inflammation.
(TIF)
S1 Table Strains used in this study.
(DOCX)
S2 Table Bottleneck estimates in iNOS- and Cybb-
deficient animals.
(DOCX)
S1 Text Supplementary materials and methods.
(DOCX)
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